116 related articles for article (PubMed ID: 28552832)
1. Decrease of ceftriaxone susceptibility in Klebsiella pneumoniae according to biofilm maturation.
Aires CP; Batista MJA; Pitondo-Silva A
J Glob Antimicrob Resist; 2017 Jun; 9():126-127. PubMed ID: 28552832
[No Abstract] [Full Text] [Related]
2. Equal, but different: Fluctuant biofilm formation and its impact on polymyxin B susceptibility among a clonal spreading of KPC-2-producing Klebsiella pneumoniae isolates.
Perez LRR
Infect Control Hosp Epidemiol; 2019 Aug; 40(8):954-955. PubMed ID: 31106716
[No Abstract] [Full Text] [Related]
3. Artificial Klebsiella pneumoniae biofilm model mimicking in vivo system: altered morphological characteristics and antibiotic resistance.
Singla S; Harjai K; Chhibber S
J Antibiot (Tokyo); 2014 Apr; 67(4):305-9. PubMed ID: 24424347
[TBL] [Abstract][Full Text] [Related]
4. Role of EDTA and CSE1034 in curli formation and biofilm eradication of Klebsiella pneumoniae: a comparison with other drugs.
Chaudhary M; Payasi A
J Antibiot (Tokyo); 2012 Dec; 65(12):631-3. PubMed ID: 23093035
[No Abstract] [Full Text] [Related]
5. Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
Pultz MJ; Donskey CJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):3044-5. PubMed ID: 17562802
[No Abstract] [Full Text] [Related]
6. Combination of essential oil and ciprofloxacin to inhibit/eradicate biofilms in multidrug-resistant Klebsiella pneumoniae.
Mohamed SH; Mohamed MSM; Khalil MS; Azmy M; Mabrouk MI
J Appl Microbiol; 2018 Jul; 125(1):84-95. PubMed ID: 29517825
[TBL] [Abstract][Full Text] [Related]
7. Activity of imipenem against Klebsiella pneumoniae biofilms in vitro and in vivo.
Chen P; Seth AK; Abercrombie JJ; Mustoe TA; Leung KP
Antimicrob Agents Chemother; 2014; 58(2):1208-13. PubMed ID: 24247132
[TBL] [Abstract][Full Text] [Related]
8. First report of polymyxin B activity in Klebsiella pneumoniae biofilm.
Herrera KMS; Silva FKD; Oliveira ME; Paiva MC; Soares AC; Siqueira Ferreira JM
J Chemother; 2019 May; 31(3):127-131. PubMed ID: 30661470
[TBL] [Abstract][Full Text] [Related]
9. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment.
Verma V; Harjai K; Chhibber S
J Antimicrob Chemother; 2009 Dec; 64(6):1212-8. PubMed ID: 19808232
[TBL] [Abstract][Full Text] [Related]
10. Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms.
Silva A; Sousa AM; Alves D; Lourenço A; Pereira MO
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27140200
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic inactivation of Klebsiella pneumoniae biofilms and planktonic cells by 5-aminolevulinic acid and 5-aminolevulinic acid methyl ester.
Liu C; Zhou Y; Wang L; Han L; Lei J; Ishaq HM; Nair SP; Xu J
Lasers Med Sci; 2016 Apr; 31(3):557-65. PubMed ID: 26886586
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of different phases of biofilm of Klebsiella pneumoniae to three different antibiotics.
Singla S; Harjai K; Chhibber S
J Antibiot (Tokyo); 2013 Feb; 66(2):61-6. PubMed ID: 23168403
[TBL] [Abstract][Full Text] [Related]
13. A simple colorimetric method for testing antimicrobial susceptibility of biofilmed bacteria.
Kim S; Kim MJ; Kang HY; Seol SY; Cho DT; Kim J
J Microbiol; 2010 Oct; 48(5):709-11. PubMed ID: 21046353
[TBL] [Abstract][Full Text] [Related]
14. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae.
Verma V; Harjai K; Chhibber S
Biofouling; 2010 Aug; 26(6):729-37. PubMed ID: 20711894
[TBL] [Abstract][Full Text] [Related]
15. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
16. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
[TBL] [Abstract][Full Text] [Related]
17. Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae.
Li Y; Zhang L; Zhou Y; Zhang Z; Zhang X
J Med Microbiol; 2018 Mar; 67(3):273-281. PubMed ID: 29458540
[TBL] [Abstract][Full Text] [Related]
18.
Paula-Ramos L; da Rocha Santos CE; Camargo Reis Mello D; Nishiama Theodoro L; De Oliveira FE; Back Brito GN; Junqueira JC; Jorge AOC; de Oliveira LD
ScientificWorldJournal; 2016; 2016():3521413. PubMed ID: 28004034
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of Moraxella catarrhalis biofilms in a continuous flow model.
Matejka KM; Bremer PJ; Tompkins GR; Brooks HJ
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):394-8. PubMed ID: 23083637
[TBL] [Abstract][Full Text] [Related]
20. The Search for Natural Inhibitors of Biofilm Formation and the Activity of the Autoinductor C6-AHL in
Cadavid E; Echeverri F
Biomolecules; 2019 Jan; 9(2):. PubMed ID: 30704099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
